胃炎

Varis K. Gastritis - a misused term in clinical gastroenterology. Scand J Gastroenterol Suppl. 1988;155:53-60.

• 摘要

Glickman JN, Antonioli DA. Gastritis. Gastrointest Endosc Clin N Am. 2001;11:717-740.

• 摘要

Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212-239.

• 全文
• 摘要

Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2037-2046.

• 全文
• 摘要

Kavitt RT, Cifu AS. Management of Helicobacter pylori infection. JAMA. 2017;317(15):1572-3.

• 摘要

Nyssen OP, McNicholl AG, Megraud F, et al. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2016;(6):CD009034.

• 全文
• 摘要

Ren Q, Yan X, Zhou Y, et al. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database Syst Rev. 2016;(2):CD009477.

• 全文
• 摘要

Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113-1124.e5.

• 全文
• 摘要

1.  Varis K. Gastritis - a misused term in clinical gastroenterology. Scand J Gastroenterol Suppl. 1988;155:53-60.

• 摘要

2.  Laine L, Weinstein WM. Subepithelial hemorrhages and erosions of human stomach. Dig Dis Sci. 1988;33:490-503.

• 摘要

3.  Glickman JN, Antonioli DA. Gastritis. Gastrointest Endosc Clin N Am. 2001;11:717-740.

• 摘要

4.  Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212-239.

• 全文
• 摘要

5.  Bondurant FJ, Maull KI, Nelson HS Jr, et al. Bile reflux gastritis. South Med J. 1987;80:161-165.

• 摘要

6.  Niemala S. Duodenogastric reflux in patients with upper abdominal complaints or gastric ulcer with particular reference to reflux-associated gastritis. Scand J Gastroenterol Suppl. 1985;115:1-56.

• 摘要

7.  Niemala S, Karttunen T, Heikkila J, et al. Characteristics of reflux gastritis. Scand J Gastroenterol. 1987;22:349-354.

• 摘要

8.  McAlhany JC Jr, Hanover TM, Taylor SM, et al. Long-term follow-up of patients with Roux-en-Y gastrojejunostomy for gastric disease. Ann Surg. 1994;219:451-455.

• 全文
• 摘要

9.  Martindale RG. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm. 2005;62(suppl 2):S11-S17.

• 摘要

10.  Kekki M, Siurala M, Varis K, et al. Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl. 1987;141:1-28.

• 摘要

11.  Shipman PJ, Drury P. Emphysematous gastritis: case report and literature review. Australas Radiol. 2001;45:64-66.

• 摘要

12.  Dharap SB, Ghag G, Biswas A. Acute necrotizing gastritis. Indian J Gastroenterol. 2003;22:150-151.

• 摘要

13.  Carlson AP, Chan WH, Ketai LH, et al. Emphysematous gastritis in a severely burned patient: case report and literature review. J Trauma. 2007;62:765-767.

• 摘要

14.  Loi T, See JY, Diddapur RK, et al. Emphysematous gastritis: a case report and a review of literature. Ann Acad Med Singapore. 2007;36:72-73.

• 摘要

15.  Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system: International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.

• 摘要

16.  Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631-636.

• 摘要

17.  Larkai EN, Smith JL, Lidsky MD, et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol. 1987;82:1153-1158.

• 摘要

18.  Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med. 1996;156:1530-1536.

• 摘要

19.  El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643-654.

• 全文
• 摘要

20.  Hunt RH, Xiao SD, Megraud F, et al; World Gastroenterology Organization. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis. 2011;20:299-304.

• 摘要

21.  MacMath TL. Alcohol and gastrointestinal bleeding. Emerg Med Clin North Am. 1990;8:859-872.

• 摘要

22.  Lanza FL, Chan FK, Quigley EM, et al. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728-738.

• 全文
• 摘要

23.  Davidson RJ, Atrah HI, Sewell HF. Longitudinal study of circulating gastric antibodies in pernicious anaemia. J Clin Pathol. 1989;42:1092-1095.

• 全文
• 摘要

24.  Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337:1441-1448.

• 摘要

25.  Torbenson M, Abraham SC, Boitnott J, et al. Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002;15:102-109.

• 全文
• 摘要

26.  Turner MA, Beachley MC, Stanley D. Phlegmonous gastritis. AJR Am J Roentgenol. 1979;133:527-528.

• 全文
• 摘要

27.  Fink DW, Boyden FM. Gas in the portal veins. A report of two cases due to ingestion of corrosive substances. Radiology. 1966;87:741-743.

• 摘要

28.  Park CW, Kim A, Cha SW, et al. A case of phlegmonous gastritis associated with marked gastric distension. Gut Liver. 2010;4:415-418.

• 全文
• 摘要

29.  Blei ED, Abrahams C. Diffuse phlegmonous gastroenterocolitis in a patient with an infected peritoneo-jugular venous shunt. Gastroenterology. 1983;84:636-639.

• 摘要

30.  Moayyedi PM, Lacy BE, Andrews CN et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988-1013.

• 全文
• 摘要

31.  Evans JA, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1-8.

• 全文
• 摘要

32.  Park WG, Shaheen NJ, Cohen J, et al. Quality indicators for EGD. Gastrointest Endosc. 2015;81(1):17-30.

• 全文
• 摘要

33.  Nurgalieva ZZ, Graham DY. Pearls and pitfalls of assessing Helicobacter pylori status. Dig Liver Dis. 2003;35:375-377.

• 摘要

34.  Cutler AF, Havstad S, Ma CK, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995;109:136-141.

• 摘要

35.  Midolo P, Marshall BJ. Accurate diagnosis of Helicobacter pylori: urease tests. Gastroenterol Clin N Am. 2000;29:871-878.

• 摘要

36.  Gisbert JP, Pajares JM. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter. 2004;9:347-368.

• 摘要

37.  Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:1921-1930.

• 摘要

38.  Uotani T, Graham DY. Diagnosis of Helicobacter pylori using the rapid urease test. Ann Transl Med. 2015;3(1):9.

• 全文
• 摘要

39.  Perna F, Ricci C, Gatta L, et al. Diagnostic accuracy of a new rapid urease test (Pronto Dry), before and after treatment of Helicobacter pylori infection. Minerva Gastroenterol Dietol. 2005;51:247-254.

• 摘要

40.  American Society of Gastrointestinal Endoscopy 2013. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013:78:216-224.

• 全文
• 摘要

41.  Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89:693S-696S.

• 全文
• 摘要

42.  Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2037-2046.

• 全文
• 摘要

43.  Lal N, Bhasin DK, Malik AK, et al. Optimal number of biopsy specimens in the diagnosis of carcinoma of the oesophagus. Gut. 1992;33:724-726.

• 全文
• 摘要

44.  Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g3174.

• 全文
• 摘要

45.  Katelaris PH, Forbes GM, Talley NJ, et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study. Gastroenterology. 2002;123:1763-1769.

• 摘要

46.  Gene E, Calvet X, Azagra R, et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther. 2003;17:1137-1143.

• 全文
• 摘要

47.  Yuan Y, Ford AC, Khan KJ, et al. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane.Database.Syst.Rev. 2013;(12):CD008337.

• 全文
• 摘要

48.  Kavitt RT, Cifu AS. Management of Helicobacter pylori infection. JAMA. 2017;317(15):1572-3.

• 摘要

49.  Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther. 2004;20:1071-1082.

• 全文
• 摘要

50.  Pan KF, Zhang L, Gerhard M, et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut. 2016;65:9-18.

• 全文
• 摘要

51.  Wong AY, Wong IC, Chui CS, et al. Association between acute neuropsychiatric events and helicobacter pylori therapy containing clarithromycin. JAMA Intern Med. 2016;176:828-834.

• 摘要

52.  De Leest HT, Steen KS, Bloemena E, et al. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. J Clin Gastroenterol. 2009;43:140-146.

• 摘要

53.  Chen H, Li X, Ge Z, et al. Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. Can J Gastroenterol. 2010;24:197-201.

• 摘要

54.  Jung JH, Choi HJ, Yoo J, et al. Emphysematous gastritis associated with invasive gastric mucormycosis: a case report. J Korean Med Sci. 2007;22:923-927.

• 全文
• 摘要

55.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2016. Intensive Care Med. 2017;43(3):304-377.

• 全文
• 摘要

56.  Rajendran S, Baban C, Lee G, et al. Rapid resolution of phlegmonous gastritis using antibiotics alone. BMJ Case Rep. 2009;2009. pii: bcr02.2009.1541.

• 全文
• 摘要

57.  Gatta L, Vakil N, Vaira D, et al. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587.

• 全文
• 摘要

58.  Liu KS, Hung IF, Seto WK, et al. Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. Gut. 2014;63:1410-1415.

• 全文
• 摘要

59.  Molina-Infante J, Romano M, Fernandez-Bermejo M, et al. Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. Gastroenterology. 2013;145:121-128.

• 摘要

60.  Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology. 2005;129:1414-1419.

• 摘要

61.  Zullo A, Gatta L, de Francesco V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther. 2005;21:1419-1424.

• 全文
• 摘要

62.  De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144:94-100.

• 摘要

63.  Zhou L, Zhang J, Chen M, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. Am J Gastroenterol. 2014;109:535-541.

• 摘要

64.  McNicholl AG, Marin AC, Molina-Infante J, et al. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut. 2014;63:244-249.

• 摘要

65.  Losurdo G, Leandro G, Principi M, et al. Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'. Int J Clin Pract. 2015;69:1112-1120.

• 摘要

66.  Kale-Pradhan PB, Mihaescu A, Wilhelm SM. Fluoroquinolone sequential therapy for helicobacter pylori: a meta-analysis. Pharmacotherapy. 2015;35:719-730.

• 摘要

67.  Nyssen OP, McNicholl AG, Megraud F, et al. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2016;(6):CD009034.

• 全文
• 摘要

68.  Saad RJ, Schoenfeld P, Kim HM, et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol. 2006;101:488-496.

• 摘要

69.  Di Mario F, Cavallaro LG, Scarpignato C. 'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis. 2006;24:113-130.

• 摘要

70.  Miehlke S, Kirsch C, Schneider-Brachert W, et al. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter. 2003;8:310-319.

• 摘要

71.  Basu PP, Rayapudi K, Pacana T, et al. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am J Gastroenterol. 2011;106:1970-1975.

• 全文
• 摘要

72.  Zeng M, Mao XH, Li JX, et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386:1457-1464.

• 摘要

73.  Sasazuki S, Hayashi T, Nakachi K, et al. Protective effect of vitamin C on oxidative stress: a randomized controlled trial. Int J Vitam Nutr Res. 2008;78:121-128.

• 摘要

74.  Li BZ, Threapleton DE, Wang JY, et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ. 2015;351:h4052.

• 全文
• 摘要

75.  Ren Q, Yan X, Zhou Y, et al. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database Syst Rev. 2016;(2):CD009477.

• 全文
• 摘要

76.  Tan B, Luo HQ, Xu H, et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. PLoS One. 2017;12(4):e0175625.

• 全文
• 摘要

77.  Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer: a population-based cohort study. Cancer. 1993 Feb 1;71(3):745-50.

• 摘要

78.  Burkitt MD, Pritchard DM. Review article: pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006;24:1305-1320.

• 摘要

79.  Kim GY, Ward J, Henessey B, et al. Phlegmonous gastritis: case report and review. Gastrointest Endosc. 2005;61:168-174.

• 摘要

80.  Fock KM, Talley N, Moayyedi P, et al; Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008;23:351-365.

• 全文
• 摘要

81.  Lee YC, Chiang TH, Chou CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150:1113-1124.e5.

• 全文
• 摘要

82.  Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085-95

• 全文
• 摘要

83.  Honda M, Hiki N, Nunobe S, et al. Preoperative vs postoperative eradication of Helicobacter pylori in 150 patients with gastric cancer: a randomized controlled trial. J Am Coll Surg. 2015;221:273-279.

• 摘要

84.  Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol. 2008;43:1448-1455.

• 摘要

85.  van Marrewijk CJ, van Oijen MG, Paloheimo LI, et al. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther. 2009;30:82-89.

• 摘要

86.  Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042-1050.

• 全文
• 摘要